Table 2.
Incremental cost-effectiveness ratio for scenario A.
| Strategy | Infection averted | Cost | IAR | ACER | ICER |
|---|---|---|---|---|---|
| Strategy 3: | 1.2325 | ||||
| Strategy 2: | 1.5835 | ||||
| Strategy 4: | 1.2914 | 0.0016 | 0.0100 | ||
| Strategy 1: | 281.1135 | 1.5793 | −0.0004 |
Incremental cost-effectiveness ratio for scenario A.
| Strategy | Infection averted | Cost | IAR | ACER | ICER |
|---|---|---|---|---|---|
| Strategy 3: | 1.2325 | ||||
| Strategy 2: | 1.5835 | ||||
| Strategy 4: | 1.2914 | 0.0016 | 0.0100 | ||
| Strategy 1: | 281.1135 | 1.5793 | −0.0004 |